Enovis - 16 Year Stock Price History | ENOV
Historical daily share price chart and data for Enovis since 2008 adjusted for splits and dividends. The latest closing stock price for Enovis as of November 19, 2024 is 45.27.
- The all-time high Enovis stock closing price was 128.95 on July 01, 2014.
- The Enovis 52-week high stock price is 65.03, which is 43.6% above the current share price.
- The Enovis 52-week low stock price is 38.27, which is 15.5% below the current share price.
- The average Enovis stock price for the last 52 weeks is 50.62.
| Enovis Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 50.4073 | 55.4400 | 63.8000 | 38.7200 | 45.2700 | -19.19% |
| 2023 | 55.7392 | 54.4000 | 65.9200 | 43.6700 | 56.0200 | 4.67% |
| 2022 | 60.2982 | 79.9312 | 80.8434 | 44.8300 | 53.5200 | -32.36% |
| 2021 | 78.5433 | 63.7866 | 91.1704 | 63.7866 | 79.1222 | 20.21% |
| 2020 | 53.1462 | 63.7005 | 66.9535 | 25.1979 | 65.8176 | 5.11% |
| 2019 | 48.9997 | 35.9897 | 62.7539 | 34.7504 | 62.6162 | 74.07% |
| 2018 | 54.7731 | 68.5370 | 71.8761 | 33.0465 | 35.9725 | -47.25% |
| 2017 | 67.9561 | 63.5112 | 74.2857 | 60.0344 | 68.1928 | 10.27% |
| 2016 | 50.2789 | 40.8606 | 68.4165 | 33.2014 | 61.8417 | 53.88% |
| 2015 | 69.9635 | 89.7418 | 92.0310 | 37.8657 | 40.1893 | -54.72% |
| 2014 | 110.5501 | 108.7608 | 128.9501 | 81.2392 | 88.7608 | -19.03% |
| 2013 | 87.6446 | 72.2719 | 109.6213 | 69.6041 | 109.6213 | 57.84% |
| 2012 | 57.0290 | 48.6231 | 69.4492 | 42.6850 | 69.4492 | 41.68% |
| 2011 | 40.1471 | 32.2719 | 54.7332 | 31.2737 | 49.0189 | 54.70% |
| 2010 | 22.9680 | 21.3081 | 32.5301 | 17.6592 | 31.6867 | 52.91% |
| 2009 | 16.6875 | 18.5198 | 23.4596 | 9.3115 | 20.7229 | 15.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.529B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.497B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.276B | 164.53 |
| Hims & Hers Health (HIMS) | United States | $5.141B | 130.72 |
| Privia Health (PRVA) | United States | $2.533B | 211.10 |
| IRhythm Technologies (IRTC) | United States | $2.362B | 0.00 |
| Azenta (AZTA) | United States | $2.001B | 99.78 |
| Omnicell (OMCL) | United States | $1.964B | 64.26 |
| Clover Health Investments (CLOV) | United States | $1.644B | 0.00 |
| 10x Genomics (TXG) | United States | $1.643B | 0.00 |
| Schrodinger (SDGR) | United States | $1.378B | 0.00 |
| Phreesia (PHR) | United States | $1.072B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
| Standard BioTools (LAB) | United States | $0.562B | 0.00 |
| Talkspace (TALK) | United States | $0.522B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.520B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.483B | 83.60 |
| Health Catalyst (HCAT) | United States | $0.459B | 0.00 |
| TruBridge (TBRG) | United States | $0.244B | 71.22 |
| Pulmonx (LUNG) | United States | $0.237B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.214B | 0.00 |
| American Well (AMWL) | United States | $0.122B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.107B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.053B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Outset Medical (OM) | United States | $0.039B | 0.00 |
| Movano (MOVE) | United States | $0.020B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |